Glenmark Pharmaceuticals has informed about a Press Release dated August 19, 2015 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Drospirenone and Ethinyl Estradiol Tablets USP, 3 mg/0.02 mg’.
The above information is a part of company’s filings submitted to BSE.